ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 224 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,229,918 | -26.7% | 26,662 | -36.3% | 0.06% | -10.6% |
| Q1 2023 | $1,677,944 | +52.9% | 41,844 | +76.7% | 0.07% | +65.0% |
| Q4 2022 | $1,097,187 | -78.5% | 23,682 | -80.8% | 0.04% | -77.7% |
| Q3 2022 | $5,101,000 | +471.2% | 123,189 | +902.0% | 0.18% | +426.5% |
| Q1 2022 | $893,000 | -15.7% | 12,294 | -2.4% | 0.03% | -17.1% |
| Q4 2021 | $1,059,000 | -90.8% | 12,590 | -90.2% | 0.04% | -90.3% |
| Q3 2021 | $11,553,000 | -22.3% | 128,100 | -17.8% | 0.42% | +24.4% |
| Q2 2021 | $14,862,000 | +1259.7% | 155,864 | +1523.6% | 0.34% | +900.0% |
| Q1 2021 | $1,093,000 | – | 9,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
| CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
| Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
| Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
| Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
| Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
| Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
| Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
| ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |